Isaacs et al listed criteria for identifying a patient who should be considered for BRCA1 and BRCA2 screening. This can help identify patients with an hereditary risk for breast, ovarian and other cancers. The authors are from Georgetown University, Memorial Sloan-Kettering Cancer Center and the University of Pennsylvania.